MPH Health Care AG Reports Strong Financial Performance in 2024

Berlin, May 28, 2025 — MPH Health Care AG, a prominent investment company in the health care sector based in Berlin, Germany, has released its annual report for 2024, showcasing a robust financial performance. The company, listed on the Xetra exchange, has once again demonstrated its ability to thrive in the competitive pharmaceuticals industry.

For the fiscal year 2024, MPH Health Care AG reported a net profit (IFRS) of €32.0 million, marking an increase from the previous year’s €29.5 million. This growth is a testament to the company’s strategic investments and operational efficiency. The operating profit, or EBIT, also saw a significant rise, increasing by 9.1% to €33.0 million from €30.2 million in 2023.

One of the highlights of the report is the improvement in the company’s equity ratio, which climbed from 94.2% to 95.5%. This increase reflects a stronger financial position, with total equity rising from €251.0 million to €277.9 million as of December 31, 2024. Such financial health is crucial for sustaining growth and pursuing new opportunities in the healthcare market.

In addition to these financial achievements, MPH Health Care AG has announced a dividend of €1.20 per share for the 2024 fiscal year. This decision underscores the company’s commitment to delivering value to its shareholders and maintaining a stable dividend policy.

The company’s success can be attributed to its focus on acquiring, developing, and selling companies and shares in the growth segments of the healthcare markets, primarily serving customers within Germany. This strategic approach has allowed MPH Health Care AG to capitalize on emerging trends and opportunities in the healthcare sector.

As of May 27, 2025, the company’s share price stood at €25.4, with a market capitalization of €109.6 million. Despite fluctuations over the past year, with a 52-week high of €35.2 and a low of €17.8, the company’s financial fundamentals remain strong.

Looking ahead, MPH Health Care AG is well-positioned to continue its growth trajectory, leveraging its robust financial performance and strategic market positioning. The company’s ability to adapt and innovate in the dynamic healthcare sector will be key to sustaining its success in the years to come.

For investors and stakeholders, MPH Health Care AG’s 2024 financial results and strategic outlook present a compelling case for continued investment in a company that is not only thriving but also committed to advancing healthcare solutions.